US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,867.50

-4.2683-0.23%

Number of Gainers:5

Number of Losers:14

Number of Flat:- -

PE:- -

High:1,871.60

Open:1,870.34

Low:1,853.56

Close:1,871.77

Volume:134.66M

Turnover:8.34B

Market Cap:1.52T

Float Cap:1.48T

Loading ...

Corvus Publishes Final Phase 1/1b Soquelitinib Data in Blood Supporting Phase 3 Relapsed/refractory PTCL Trial

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1B T Cell Lymphoma Trial

THOMSON REUTERS

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Offering

Moderna to Offer $2 Billion of Convertible Senior Notes Due 2032

MT Newswires Live

Moderna Shares Down 5.6% Premarket After Co Announces Proposed Private Placement of $2 Bln of Convertible Senior Notes

THOMSON REUTERS

Moderna: Announces Proposed Private Placement of $2.0 Bln of Convertible Senior Notes

THOMSON REUTERS

Moderna: to Buy Hedge Overlay Intended to Offset Dilution up to a Cap Initially Equal to at Least a 150% Premium to the Stock Price at Pricing

THOMSON REUTERS

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS

AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals

China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy

EQ Resources Names New Director, Reports No Share Interests

EQ Resources Names New Director and Discloses Equity Interests

24H | Okta Soars 21%; Salesforce Jumps 13%; CrowdStrike Rallies 10%; NVIDIA Climbs 4.6%

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Vaxart granted European patent covering oral norovirus vaccine through 2036

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Vaxart Wins European Patent Covering Oral Norovirus Vaccine Technology

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK4568/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1867.5006,"timestamp":1787947199999,"preClose":1871.7689,"halted":0,"volume":134664115,"delay":0,"changeRate":-0.00228,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-4.268311,"latestTime":"08-28 16:00:00 EDT","open":1870.3362,"high":1871.5975,"low":1853.5558,"amount":8337632035.877626,"amplitude":0.009639,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.8712,"peRate":47.437581,"turnoverRate":0.009719,"increases":5,"decrements":14,"flats":0,"marketCap":1519699775812,"floatMarketCap":1484485215242.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1871.5975,"amplitude":0.009639,"preClose":1871.7689,"low":1853.5558,"pbRate":"4.8712","latestPrice":1867.5006,"volume":134664115,"delay":0,"open":1870.3362,"prevYearClose":1637.1339,"prevWeekClose":1897.2026,"prevMonthClose":1741.4208,"prevQuarterClose":1731.2963,"fiveDayClose":1897.2026,"twentyDayClose":1741.4208,"sixtyDayClose":1610.6455,"secType":"PLATE","market":"US","turnoverRate":0.009719,"peRate":47.437581,"marketCap":1519699775812,"floatMarketCap":1484485215242.5,"timestamp":1787947199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662701725","title":"Corvus Publishes Final Phase 1/1b Soquelitinib Data in Blood Supporting Phase 3 Relapsed/refractory PTCL Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701725?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:31","pubTimestamp":1787830316,"startTime":"0","endTime":"0","summary":"Corvus publishes final Phase 1/1b soquelitinib data in Blood supporting Phase 3 relapsed/refractory PTCL trialCorvus reported peer-reviewed final Phase 1/1b data for soquelitinib in T-cell lymphoma pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL7f0fc2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","CRVS","SG9999014039.USD","BK4139","BCDF","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","SG9999014013.SGD","BK4585","IE00BQXX3C00.GBP","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","BK4568","IE00BKPKM429.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270125","title":"Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1B T Cell Lymphoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270125","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270125?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:30","pubTimestamp":1787830201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUARHD1T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","CRVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370164","title":"Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370164","media":"Reuters","labels":["shareholding","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662370164?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:27","pubTimestamp":1787830056,"startTime":"0","endTime":"0","summary":"Moderna plans private placement of $2 billion convertible senior notes offeringModerna launched a private placement of USD 2 billion convertible senior notes due 2032.Initial purchasers hold an option","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL4hm6C0:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Offering","news_tag":"shareholding,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4532","IDNA","MRNX","BK4568","BK4533","BK4588","BK4548","BK4551","BK4501","BK4585","MRNY","GNOM","WDNA","BK4534","BK4139","LGHT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2662701125","title":"Moderna to Offer $2 Billion of Convertible Senior Notes Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701125","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701125?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:27","pubTimestamp":1787830048,"startTime":"0","endTime":"0","summary":"Moderna to Offer $2 Billion of Convertible Senior Notes Due 2032","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","MRNX","BK4533","LGHT","WDNA","GNOM","BK4548","BK4532","MRNA","BK4551","IDNA","MRNY","BK4534","BK4585","BK4588","BK4139","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701115","title":"Moderna Shares Down 5.6% Premarket After Co Announces Proposed Private Placement of $2 Bln of Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701115?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:26","pubTimestamp":1787829980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O14I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNX","BK4532","BK4548","BK4534","BK4501","BK4568","BK4588","GNOM","MRNA","MRNY","BK4533","LGHT","IDNA","WDNA","BK4551","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701618","title":"Moderna: Announces Proposed Private Placement of $2.0 Bln of Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701618","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701618?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:21","pubTimestamp":1787829702,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O13J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4532","BK4548","BK4139","BK4588","BK4501","BK4568","MRNA","MRNX","MRNY","WDNA","BK4585","BK4551","BK4533","IDNA","LGHT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662016207","title":"Moderna: to Buy Hedge Overlay Intended to Offset Dilution up to a Cap Initially Equal to at Least a 150% Premium to the Stock Price at Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662016207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662016207?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:21","pubTimestamp":1787829702,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O13J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","IDNA","BK4585","BK4501","WDNA","BK4534","BK4532","LGHT","MRNY","MRNX","GNOM","BK4568","BK4139","BK4548","MRNA","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662013447","title":"Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2662013447","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662013447?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:15","pubTimestamp":1787829352,"startTime":"0","endTime":"0","summary":"Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis showed that AstraZeneca (AZN) and Amgen’s (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PJP","TBXU","BBH","BK4568","LU0128525929.USD","LU1023059063.AUD","IBB","IE00B3T34201.USD","LU2237443978.SGD","LU2462157665.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU2417539215.USD","LU1267930573.SGD","AZN","IBBQ","LU2242652126.USD","LU0289739699.SGD","BK4566","LU0868494617.USD","LU2236285917.USD","LU2456880835.USD","BK4139","LU2242646821.SGD","PBE","LU2237443622.USD","AMGN","LU0122379950.USD","LU0708994859.HKD","IE00BFTCPJ56.SGD","LU2089984988.USD","IE0009355771.USD","IE0002141913.USD","LU2237443465.HKD","LU1829250122.USD","IE00BJJMRZ35.SGD","LU0029864427.USD","BK4534","BK4533","AZNH","IE00B2B36J28.USD","LU2237443382.USD","LU0432979614.USD","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","BIB","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2112291526.USD","LU0058720904.USD","BK4568","AZNH","IE0002141913.USD","BK4588","AMGN","IE00BJT1NW94.SGD","LU1267930573.SGD","BK4007","LU0128525929.USD","LU2468319806.SGD","PBE","LU0889565916.HKD","PJP","LU0122379950.USD","TBXU","IE00BJJMRZ35.SGD","IBB","LU0320765992.SGD","LU1061106388.HKD","LU1571399168.USD","LU2417539215.USD","BK4533","BK4581","BK4599","AZN","IBBQ","IE00B2B36J28.USD","LU2237443895.HKD","LU1829250122.USD","BK4585","LU1057294990.SGD","LU2236285917.USD","LU2237443465.HKD","LU2237443978.SGD","IE0009355771.USD","LU1983299246.USD","BK4566","BIB","LU1023059063.AUD","IE00B3T34201.USD","BBH","LU0029864427.USD","LU2456880835.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU2242646821.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477411","title":"Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477411?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:47","pubTimestamp":1787820442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1506573853.SGD","LU0882574055.USD","BK4588","LU1244550221.USD","JNJ","MEDX","IE00BDGV0183.EUR","GDOC","TRUH","LU0994945656.USD","RXL","IE00BSNM7G36.USD","LU1244550494.USD","IE00BLSP4239.USD","LU1066053197.SGD","XLV","IE00BVYPNV92.GBP","IE0002270589.USD","LU1066051498.USD","LU0640476718.USD","LU1551013425.SGD","LU2347655156.SGD","LU2129689514.USD","IXJ","FHLC","LU1032466523.USD","LU2896262040.SGD","BK4568","LU2471134523.USD","VHT","LU1196500208.SGD","JDOC","FTXH","IE00B42XCP33.USD","IYH","BMED","LU0943347566.SGD","IHE","LU1894683264.USD","BK4532","IE00BN8TJ469.HKD","IE000MB6IJN5.SGD","LU2592432038.USD","PJP","LU2505996681.GBP","IE00BFXG1179.USD","IE0009355771.USD","LU0053666078.USD","SG9999001176.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662101775","title":"AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2662101775","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662101775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:52","pubTimestamp":1787813520,"startTime":"0","endTime":"0","summary":"AstraZeneca reported positive results from its Phase 3 trial of Tezspire in patients with eosinophilic esophagitis, an inflammatory disorder of the esophagus.The Cambridge-based pharmaceutical company said Thursday that the drug demonstrated improvements across co-primary and all key secondary endpoints at week 24 of the trial, which were sustained to week 52.The co-primary endpoints were histologic remission and the frequency and severity of dysphagia--or difficulty swallowing--compared with the placebo. The safety profile of the drug was generally consistent with its approved indications, AstraZeneca added.The drug is being developed in collaboration with U.S. biotechnology company Amgen.Tezspire is currently approved for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps in the U.S., EU, China and Japan.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","BK4585","AZN","LU2237443895.HKD","LU0109394709.USD","LU2237443978.SGD","BK4568","LU2417539215.USD","LU2468319806.SGD","LU0708994859.HKD","LU2456880835.USD","LU1267930573.SGD","AZNH","IE00B3T34201.USD","LU0889565916.HKD","LU0432979614.USD","LU0029864427.USD","BK4588","LU2237443382.USD","LU2237443465.HKD","LU2237443622.USD","LU2236285917.USD","LU0058720904.USD","LU2089984988.USD","LU0289739699.SGD","LU0128525929.USD","LU0320765992.SGD","LU2237443549.SGD","LU1829250122.USD","LU0310800379.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662727075","title":"China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662727075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662727075?lang=en_us&edition=fundamental","pubTime":"2026-08-27 12:42","pubTimestamp":1787805765,"startTime":"0","endTime":"0","summary":"UPDATE 2-China's drug regulator accepts Novo Nordisk's application for oral WegovySHANGHAI, Aug 27 (Reuters)-Novo NordiskNOVOb.COsaid on Thursday that China's drug regulator had accepted its applicati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O09E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SG9999002224.SGD","SG9999011175.SGD","01801","LU1894683264.USD","LU0225771236.USD","LU0985481810.HKD","BK4599","HK0000165453.HKD","LU0463099449.HKD","LU2097828474.EUR","00673","LU2097828631.EUR","IE00B19Z3B42.SGD","IE00BBT3K403.USD","BK1583","LU2596442595.SGD","IE00BLSP4239.USD","BK4581","LU0502904849.HKD","BK4533","LU0321505868.SGD","OZEM","BK1589","SG9999001176.SGD","BK1197","LU1894683348.USD","IE000M9KFDE8.USD","BK4588","IE00B19Z3581.USD","LU2242644610.SGD","PFE","SGXZ57979304.SGD","BK1161","IE0002270589.USD","IE00BLSP4452.SGD","LU0868494617.USD","LU2097828557.USD","BK4568","SG9999002232.USD","LU0170899867.USD","LU0456855351.SGD","LU1057294990.SGD","KURE","LU0321505439.SGD","LU0122379950.USD","SG9999001176.USD","LU0058720904.USD","LU2328871848.SGD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662218687","title":"EQ Resources Names New Director, Reports No Share Interests","url":"https://stock-news.laohu8.com/highlight/detail?id=2662218687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662218687?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:18","pubTimestamp":1787793489,"startTime":"0","endTime":"0","summary":"The latest update is out from EQ Resources Limited ( ($AU:EQR) ). EQ Resources Limited has appointed Nicole Anne Brook as a director effective 25 A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-reports-no-share-interests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-reports-no-share-interests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662072186","title":"EQ Resources Names New Director and Discloses Equity Interests","url":"https://stock-news.laohu8.com/highlight/detail?id=2662072186","media":"TIPRANKS","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662072186?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:18","pubTimestamp":1787793481,"startTime":"0","endTime":"0","summary":"EQ Resources Limited ( ($AU:EQR) ) has issued an announcement. EQ Resources Limited has appointed Constandinos Dermedgoglou as a director effective...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-and-discloses-equity-interests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-and-discloses-equity-interests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","BK4139","BK4588","BK4568","REZ","EQR","BK4585","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134315111","title":"24H | Okta Soars 21%; Salesforce Jumps 13%; CrowdStrike Rallies 10%; NVIDIA Climbs 4.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134315111","media":"US Overnight","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134315111?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:11","pubTimestamp":1787789472,"startTime":"0","endTime":"0","summary":"Dow Futures rose 0.41%, S&P 500 Futures rose 0.57%, Nasdaq Futures rose 1.11% as AI-linked tech strength reflected a broadly risk-on tone.Okta Inc. jumped 20.89%. Earnings beat and a second full-year...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"64560525f7164c3f97e05313b2714ccc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STX","BK4097","LU0353189680.USD","LU2433249047.HKD","BK4567","BK4560","ARMG","LU1914381329.SGD","LU0823434583.USD","LU0234572021.USD","VGT","BK4575","LU2125909916.SGD","LU1989764664.SGD","LU0057025933.USD","LU1548497426.USD","LU2125909593.SGD","HAKY","LU0310799852.SGD","BK4607","LU0052756011.USD","GB00BDT5M118.USD","LU0820561818.USD","IE00BJLML261.HKD","LU2098885051.SGD","BK4585","LEGR","LU0320765059.SGD","LU0689626769.HKD","LU1496350171.SGD","MRNA","LU1992135399.USD","LU2896262040.SGD","IDNA","LU0154236417.USD","MUYY","EMSF","BK4551","LU0889565833.HKD","IE00B894F039.SGD","LU2265009873.SGD","CIBR","IE00BK4W5M84.HKD","USXF","LU0689472784.USD","BK4533","FXL","LU0708995401.HKD","IE00BWXC8680.SGD","LU0130517989.USD","SGXZ81514606.USD","BK4170","LU2357627491.SGD","LU0096364046.USD","IE00B19Z3B42.SGD","LU0203347892.USD","SMU00main","LU0124676726.USD","MRVL","DRMY","LU1815336760.USD","LU0820561909.HKD","IE00BZ9MQY76.HKD","LU1261432733.SGD","MUD","BK4535","LU1778281490.HKD","LU0267386448.USD","LU1496350502.SGD","LU0109391861.USD","LU1814569148.SGD","BOBP","ARMA","CRWC","LU0642271901.SGD","BK4501","BK4543","LU0719512351.SGD","LU2213496289.HKD","LU0683600562.USD","LU1280957306.USD","XNTK","LU1551013342.USD","LU0353189763.USD","IE000M9KFDE8.USD","BK4568","CHPS","LU2357305700.SGD","LU0056508442.USD","LU2543165471.USD","LU0823421416.USD","LU1267930730.SGD","AIS","LU1674673691.USD","MU","LU0238689110.USD","LU0314104364.USD","LU1201861249.SGD","BK4609","CRM","LU0472753341.HKD","IE0002270589.USD","IE00BBT3K403.USD","LU2272731600.USD","LU1992135472.HKD","LU0006306889.USD","EFIV","CRWD","BK4604","HBMX","LU0198837287.USD","IE00B7SZLL34.SGD","IE00B19Z9505.USD","LU1169590202.USD","FCUS","XLK","LU1868836591.USD","LU2361044865.SGD","LU1323610961.USD","LU0130518102.USD","LU1791710400.SGD","DTCR","BK4515","IGV","EGGY","LU0048573561.USD","LU0251142724.SGD","LU2048586759.USD","LU2361044949.HKD","LU2322448957.HKD","IE00BMPRXQ63.HKD","LU0289961442.SGD","LU1267930490.SGD","LU0310800965.SGD","IETC","BK7142","MUU","BK4505","LU1917777945.USD","WCBR","RULE","LU0957808578.USD","LU2102340556.USD","LU2236285917.USD","LU2458330243.SGD","IE00B19Z9Z06.USD","IE00BKVL7J92.USD","LU1232071149.USD","LU2458330169.SGD","LU2168564495.EUR","LU1551013425.SGD","LU0289739343.SGD","LU0061475181.USD","LU1720051017.SGD","LU0274383776.USD","BK4139","BK4588","LU0477156797.USD","LU1791710582.SGD","MRVU","GNOM","BK4579","IE00BJTD4N35.SGD","LU2471134879.HKD","BK4554","SOXY","IE00BJTD4V19.USD","LU2360107168.USD","LU0127658192.USD","LU2272731865.HKD","IE00B5949003.HKD","LU1923622614.USD","LU2168564149.EUR","IE00BN8TJ469.HKD","TRFK","PSI","STXL","LU1803068979.SGD","LU1303367103.USD","MUZ","LU2168564222.USD","LU0211327993.USD","LU1923623000.USD","ARM","LU0251131958.USD","LU0354030511.USD","LU0106261372.USD","BK4613","LU2089985449.USD","LU0444971666.USD","LU1861220033.SGD","LU2756315318.SGD","WDNA","LU0820562030.AUD","LU1674673428.USD","LU0109392836.USD","LU2106854487.HKD","LU1145028129.USD","SOXX","PSWD","LU0742534661.SGD","CRMG","WLDR","LU0157215616.USD","GTEK","MRVX","CLOD","LU2247934214.USD","CRWL","LU2473716301.USD","LU1169589451.USD","ARMU","SGXZ51526630.SGD","LU1235294995.USD","BK4532","LU1951200564.SGD","DISK","LU2361045086.USD","LU1064131342.USD","LU2756315664.SGD","LU0672654240.SGD","IE00BSNM7G36.USD","LU1642822529.SGD","IE00BLSP4452.SGD","SHOC","LU2360106780.USD","LU2290526834.HKD","LU1868836914.USD","IE00BQXX3C00.GBP","BK4581","LU0640476718.USD","LU2125909247.SGD","LU0128525689.USD","SMHX","BK4566","LU0417517546.SGD","LU1267930813.SGD","IE00B19Z8W00.USD","PTF","LU1670628061.USD","IE00BK4W5L77.USD","IE0004091025.USD","LU0266013472.USD","LU2931357623.SGD","LU1868837300.USD","MRNX","LU0477156953.USD","LU1804176565.USD","LGHT","ARMW","AIFD","BK4598","BK4528","MUG","LU2461242641.AUD","LU1983260115.SGD","IE00B1XK9C88.USD","LU0203345920.USD","LU0889566641.SGD","LU0234570918.USD","BAI","IE0004086264.USD","SOXQ","LU1923622291.USD","LU2403377893.USD","LU0323591593.USD","LU1989764748.USD","LU0069063385.USD","SOXS","SOXL","LU1366333091.USD","LU0348723411.USD","LU1951198990.SGD","LU2244417387.USD","LU0476273544.USD","SPRX","LU2023250330.USD","IE00BLSP4239.USD","LU1046421795.USD","BK4512","LU0792757196.USD","QQQA","BK4553","BK4561","LU0211328371.USD","LU0256863902.USD","CGGO","LU0786609619.USD","LU0444973449.USD","AIQ","LU2286300806.USD","LU0210536198.USD","SGXZ99366536.SGD","LU2168564065.EUR","LU0823421333.USD","IE00B19Z8X17.USD","LU0557290698.USD","LU1084165304.USD","IE00B19Z3581.USD","FTEC","LU2250418816.HKD","QQQG","LU1988902786.USD","BK4534","LU0964807845.USD","LU0133085943.USD","LU0787776722.HKD","LU0256863811.USD","LU2087625088.SGD","IE0009356076.USD","LU0130102774.USD","LU2471134523.USD","FAI","STXX","BK4141","BK4550","SG9999000418.SGD","LU0187121727.USD","JGRO","MIC","AIPI","SG9999001424.SGD","LU2750360641.GBP","LU2168563687.JPY","IE00BQXX3D17.EUR","STX.AU","LU1670627923.USD","BK4605","IE00B19Z9P08.USD","IE00BMPRXR70.SGD","LU1823568750.SGD","LU1974910355.USD","LU2023250504.SGD","LU0980610538.SGD","MVLL","WUGI","LU1629891620.HKD","STXU","LU2272731782.SGD","MRNY","SPAM","LU1201861165.SGD","LU2211815571.USD","BUG","CHPX","TTXU","IE00BQXX3F31.USD","LU0648001328.SGD","LU2750360997.AUD","IXN","LU1267930227.SGD","LU2264538146.SGD","SMH","LU0528227936.USD","LU2471134796.USD","LU1868837136.USD","BK4527","LU0354030438.USD","LU0943347566.SGD","LU0511384066.AUD","LU0082616367.USD","BK4023","IE0034235303.USD","BK4548","LU1868836757.USD","FDTX","MULL","LU0081259029.USD","FTXL","IE00BKDWB100.SGD","LU1316542783.SGD","LU0859254822.USD","BK4538","IE00BMPRXN33.USD","LU2125909759.SGD","BK4608","LU0130103400.USD","LU1119994496.HKD","LU1852331112.SGD","LU2054465674.USD","IE00BZ1G4Q59.USD","LU0648000940.SGD","LU2471134952.CNY","LU1720051108.HKD","LU1861215975.USD","LU0823434740.USD","LU2322448791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662747915","title":"Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662747915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662747915?lang=en_us&edition=fundamental","pubTime":"2026-08-27 05:28","pubTimestamp":1787779680,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  slipped 2.44% to $9.21 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.08% to 26,130.20 and Dow Jones Industrial Average  falling 0.21% to 53,463.88.Novavax Inc. closed 23.06% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.15% to $270.00, Pfizer Inc.  fell 0.95% to $28.30, and Merck & Co. Inc.  fell 2.14% to $153.10.Trading volume  remained 575,344 below its 50-day average volume of 4.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4547","NVAX","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662449742","title":"Vaxart granted European patent covering oral norovirus vaccine through 2036","url":"https://stock-news.laohu8.com/highlight/detail?id=2662449742","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662449742?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:50","pubTimestamp":1787777417,"startTime":"0","endTime":"0","summary":"Vaxart (VXRT) announced that the European Patent Office formally published the grant of European Patent No. 3791859 effective August 26. This paten...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vaxart-granted-european-patent-covering-oral-norovirus-vaccine-through-2036-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vaxart-granted-european-patent-covering-oral-norovirus-vaccine-through-2036-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPV","BK4139","USRD","VXRT","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662674408","title":"Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662674408","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662674408?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:35","pubTimestamp":1787776500,"startTime":"0","endTime":"0","summary":"DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  shed 1.75% to $114.10 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88.This was the stock's second consecutive day of losses.Abbott Laboratories closed 17.01% short of its 52-week high of $137.49, which the company reached on September 22nd.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.15% to $270.00, Pfizer Inc.  fell 0.95% to $28.30, and Merck & Co. Inc.  fell 2.14% to $153.10.Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ41872573.SGD","BK4566","BK4588","LU0211331839.USD","SGXZ23171101.USD","IE00B2B36J28.USD","BK4581","LU1691799644.USD","PJP","LU2133065610.SGD","IE0002141913.USD","SG9999002232.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","LU2237957902.USD","LU1989763427.SGD","LU0868494617.USD","LU0208291251.USD","SG9999004303.SGD","LU0320765489.SGD","LU1989763690.USD","LU2324357040.USD","LU2211815571.USD","IHI","IE0009355771.USD","LU1061106388.HKD","LU2089984988.USD","LU2237957811.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1721429741.USD","BK4533","ABT","LU2468319806.SGD","LU1057294990.SGD","SG9999002224.SGD","LU0114720955.EUR","BK4568","LU0882574055.USD","LU1023059063.AUD","LU1721429402.USD","LU0289739699.SGD","BK4585","LU0266013472.USD","BK4082","LU0070302665.USD","LU0170899867.USD","LU2112291526.USD","LU0122379950.USD","LU1914381329.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4504","LU0234572021.USD","TMED","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744384","title":"Vaxart Wins European Patent Covering Oral Norovirus Vaccine Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744384","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744384?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:12","pubTimestamp":1787775134,"startTime":"0","endTime":"0","summary":"Vaxart wins European patent covering oral norovirus vaccine technologyVaxart won a new European patent covering key technology behind its oral recombinant norovirus vaccine candidate.The European Pate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL74MbxS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874109","title":"Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874109?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:07","pubTimestamp":1787774862,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","VXRT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":5,"totalSize":385,"code":"91000000","status":"200"}]}}